XELSTRYM
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Nov 2022)
What this means for you
This application is over — abandoned 21 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88411346
- Mark type
- Stylized text
- Filed
- 01 May 2019
- Published for opposition
- 20 Aug 2019
- Abandoned
- 21 Nov 2022
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of disorders of the central nervous system, namely, a transdermal amphetamine patch for treating ADD or ADHD
Owner
- Noven Therapeutics, LLC, Miami, FL, US
- Noven Therapeutics, LLC, Miami, FL, US
Prosecution history
- 21 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 17 May 2022 — ASSIGNED TO EXAMINER
- 24 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Mar 2022 — SOU EXTENSION 5 GRANTED
- 15 Mar 2022 — SOU EXTENSION 5 FILED
- 23 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Sept 2021 — SOU EXTENSION 4 GRANTED
- 28 Sept 2021 — SOU EXTENSION 4 FILED
- 28 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 16 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2021 — SOU EXTENSION 3 GRANTED
- 12 Mar 2021 — SOU EXTENSION 3 FILED